# Innoviva, Inc.: filings

INVA · Nasdaq · CIK 1080014 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inva.md) · [Financials](/companies/inva/financials.md) · [Filings](/companies/inva/filings.md) · [Insiders](/companies/inva/insiders.md)

## Reports and events: 473 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 572, 8-K 342, SC 13G/A 77, 10-Q 53, 3 35, DEFA14A 32, SC 13D/A 22, DFAN14A 21, 10-K 18, DEF 14A 17, UPLOAD 15, 4/A 12, CORRESP 11, SC 13G 11, 10-K/A 8, 8-K/A 8, S-8 8, CT ORDER 7, 3/A 6, SCHEDULE 13G/A 6, SC TO-I/A 6, SC TO-C 5, FWP 4, SC TO-T/A 4, 424B5 3, 5 3, ARS 3, SC 13D 3, DEFC14A 2, PRE 14A 2, PREC14A 2, SC 13E3/A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SC TO-T 2, 144 1, 425 1, EFFECT 1, PRRN14A 1, S-3 1, S-3ASR 1, SC 13E3 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:26 ET | [10-Q](/filings/0001193125-26-335235.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335235 |
| 2026-08-05 | 16:19 ET | [8-K](/filings/0001193125-26-335192.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335192 |
| 2026-05-18 | 16:21 ET | [8-K](/filings/0001193125-26-228958.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-228958 |
| 2026-05-06 | 16:29 ET | [10-Q](/filings/0001193125-26-209110.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209110 |
| 2026-05-06 | 16:19 ET | [8-K](/filings/0001193125-26-209044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209044 |
| 2026-05-04 | 16:59 ET | [8-K](/filings/0001193125-26-204243.md) | 5.07 Shareholder vote results | 0001193125-26-204243 |
| 2026-03-27 | 16:01 ET | [10-K/A](/filings/0001193125-26-128939.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-128939 |
| 2026-03-24 | 16:51 ET | [DEF 14A](/filings/0001140361-26-010912.md) | Proxy statement, period 2026-03-24 | 0001140361-26-010912 |
| 2026-02-25 | 16:57 ET | [8-K](/filings/0001193125-26-071974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071974 |
| 2026-02-25 | 16:31 ET | [10-K](/filings/0001193125-26-071776.md) | Annual report, period 2025-12-31 | 0001193125-26-071776 |
| 2025-11-05 | 16:28 ET | [10-Q](/filings/0001193125-25-267040.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267040 |
| 2025-11-05 | 16:18 ET | [8-K](/filings/0001104659-25-107014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107014 |
| 2025-08-06 | 16:27 ET | [10-Q](/filings/0000950170-25-104126.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104126 |
| 2025-08-06 | 16:21 ET | [8-K](/filings/0001104659-25-074730.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074730 |
| 2025-05-21 | 16:15 ET | [8-K](/filings/0001104659-25-051614.md) | 5.07 Shareholder vote results | 0001104659-25-051614 |
| 2025-05-07 | 16:30 ET | [10-Q](/filings/0000950170-25-065765.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065765 |
| 2025-05-07 | 16:16 ET | [8-K](/filings/0001104659-25-045556.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045556 |
| 2025-04-08 | 16:05 ET | [DEF 14A](/filings/0001193125-25-075695.md) | Proxy statement, period 2025-05-19 | 0001193125-25-075695 |
| 2025-03-24 | 16:15 ET | [10-K/A](/filings/0000950170-25-043848.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-043848 |
| 2025-03-17 | 21:31 ET | [SCHEDULE 13D/A](/filings/0000899140-25-000427.md) | Ownership report, active investor, amended | 0000899140-25-000427 |
| 2025-03-07 | 21:30 ET | [SCHEDULE 13D/A](/filings/0000899140-25-000411.md) | Ownership report, active investor, amended | 0000899140-25-000411 |
| 2025-02-26 | 16:48 ET | [10-K](/filings/0000950170-25-027864.md) | Annual report, period 2024-12-31 | 0000950170-25-027864 |
| 2025-02-26 | 16:37 ET | [8-K](/filings/0001104659-25-017461.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-017461 |
| 2024-11-06 | 16:25 ET | [10-Q](/filings/0000950170-24-122375.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122375 |
| 2024-11-06 | 16:18 ET | [8-K](/filings/0001104659-24-114800.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-114800 |
| 2024-07-31 | 16:47 ET | [10-Q](/filings/0000950170-24-088661.md) | Quarterly report, period 2024-06-30 | 0000950170-24-088661 |
| 2024-07-31 | 16:17 ET | [8-K](/filings/0001104659-24-084357.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-084357 |
| 2024-06-20 | 16:30 ET | [8-K](/filings/0001104659-24-073416.md) | 5.07 Shareholder vote results | 0001104659-24-073416 |
| 2024-05-13 | 09:27 ET | [8-K](/filings/0001104659-24-060280.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-060280 |
| 2024-05-08 | 16:46 ET | [10-Q](/filings/0000950170-24-055832.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055832 |
| 2024-05-08 | 16:44 ET | [8-K](/filings/0001104659-24-058747.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058747 |
| 2024-04-30 | 18:14 ET | [8-K](/filings/0001193125-24-123033.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-123033 |
| 2024-04-29 | 17:25 ET | [DEF 14A](/filings/0001193125-24-122923.md) | Proxy statement, period 2024-06-17 | 0001193125-24-122923 |
| 2024-03-22 | 16:42 ET | [10-K/A](/filings/0000950170-24-035419.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-035419 |
| 2024-03-05 | 18:14 ET | [10-K/A](/filings/0000950170-24-025088.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-025088 |
| 2024-02-29 | 17:01 ET | [10-K](/filings/0000950170-24-023237.md) | Annual report, period 2023-12-31 | 0000950170-24-023237 |
| 2024-02-29 | 16:15 ET | [8-K](/filings/0001104659-24-029378.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-029378 |
| 2023-11-06 | 08:30 ET | [8-K](/filings/0001104659-23-114509.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-114509 |
| 2023-11-01 | 16:44 ET | [10-Q](/filings/0000950170-23-057530.md) | Quarterly report, period 2023-09-30 | 0000950170-23-057530 |
| 2023-11-01 | 16:30 ET | [8-K](/filings/0001104659-23-113410.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-113410 |
| 2023-08-25 | 17:24 ET | [8-K](/filings/0001104659-23-095406.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-095406 |
| 2023-08-07 | 16:42 ET | [8-K](/filings/0001104659-23-088390.md) | 3.01 Delisting notice | 0001104659-23-088390 |
| 2023-08-02 | 17:02 ET | [10-Q](/filings/0000950170-23-037296.md) | Quarterly report, period 2023-06-30 | 0000950170-23-037296 |
| 2023-08-02 | 16:15 ET | [8-K](/filings/0001104659-23-086806.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-086806 |
| 2023-07-11 | 08:16 ET | [8-K](/filings/0001104659-23-079823.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-079823 |
| 2023-05-24 | 17:18 ET | [8-K](/filings/0001104659-23-064192.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-064192 |
| 2023-05-24 | 18:07 ET | [8-K](/filings/0001104659-23-063704.md) | 5.07 Shareholder vote results | 0001104659-23-063704 |
| 2023-05-15 | 17:05 ET | [SC 13D/A](/filings/0000899140-23-000652.md) | Ownership report, active investor, amended | 0000899140-23-000652 |
| 2023-05-09 | 17:21 ET | [8-K](/filings/0001104659-23-057825.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-057825 |
| 2023-05-09 | 17:05 ET | [10-Q](/filings/0000950170-23-019835.md) | Quarterly report, period 2023-03-31 | 0000950170-23-019835 |

Page 1 of 10. [Older](/companies/inva/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.